Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial
Clinical trial NCT07349771 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07349771
- Sponsor
- Mayo Clinic
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2028-06-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.